A Prescription from Hell — OxyContin 12-hour

A sensational investigative report by by Harriet Ryan, Lisa Girion and Scott Glover in the Los Angeles Times (May 5, 2016) exposes the irresponsible, corrupt practices of Purdue Pharmaceuticals, the company that manufactures and aggressively markets OxyContin at a dosing schedule that some . . . Continue reading →

Petition to FDA: Withdraw Aricept 23mg Immediately

Public Citzen petitioned  FDA Commissioner to immediately removal from market Pfizer’s Alzheimer’s drug, Aricept  23 mg dose, because of serious safety hazards and failure to demonstrate efficacy. The petition also urges FDA to add a label warning on Aricept and generic donepezil (5 mg and 10 mg) stating: "Use of 20 mg per day is counter indicated."

Continue reading →

Devastating FDA Safety Review of Avandia

Evidence that GlaxoSmithKline concealed adverse events in their trial testing their diabetes drug, Avandia, raises the question “whether the entire system is corrupt.” “To the extent that we can’t trust the data. We are in jeopardy of giving patients the wrong drugs.” Dr. Jerome Kassirer
Continue reading →

Florida Antipsychotic Pre-Approval Requirement Protects PreschoolChildren

The State of Florida has established a pre-approval requirement to protect preschool children on Medicaid from being exposed to the hazardous effects of antipsychotic drugs. That step has prompted "a seismic change" in doctors’ inappropriate prescribing of antipsychotics for preschool children: the . . . Continue reading →